zirconium has been researched along with Hypoxia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
An, JH; Hong, SE; Hwang, WM; Kang, J; Lee, DC; Lee, HY; Park, CG; Park, HW; Park, MH; Yoon, KR; Yoon, SH; Yu, SL; Yun, SR | 1 |
Boerman, OC; Bussink, J; Franssen, GM; Hoeben, BA; Kaanders, JH; Oosterwijk, E; Oyen, WJ; Rijken, PF; Troost, EG; van Dongen, GA | 1 |
2 other study(ies) available for zirconium and Hypoxia
Article | Year |
---|---|
Ceria-Zirconia Antioxidant Nanoparticles Attenuate Hypoxia-Induced Acute Kidney Injury by Restoring Autophagy Flux and Alleviating Mitochondrial Damage.
Topics: Acute Kidney Injury; Antioxidants; Apoptosis; Autophagy; Humans; Hypoxia; Nanoparticles; Oxidative Stress; Reactive Oxygen Species; Zirconium | 2020 |
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Carbonic Anhydrase Inhibitors; Head and Neck Neoplasms; Hypoxia; Image Processing, Computer-Assisted; Immunoglobulin Fab Fragments; Immunoglobulin G; Immunohistochemistry; Isotope Labeling; Mice; Mice, Inbred BALB C; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Quality Control; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays; Zirconium | 2010 |